Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
Current Opinion in Toxicology|May 2, 2017
The Aryl Hydrocarbon Receptor (AhR) as a Drug Target for Cancer ChemotherapyStephen Safe, Yating Cheng, Un-Ho JinThe Journal of Pharmacology and Experimental Therapeutics|August 11, 2012
Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cellsUn-Ho Jin, Syng-ook Lee, Stephen SafeToxicological Sciences : an Official Journal of the Society of Toxicology|June 18, 2013
Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug targetStephen Safe, Syng-Ook Lee, Un-Ho JinArchives of Toxicology|May 17, 2017
Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug targetSiva Kumar Kolluri, Un-Ho Jin, Stephen SafeChemical Research in Toxicology|April 1, 2015
Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor PathwayUn-Ho Jin, Sang-Bae Kim, Stephen SafeMolecular Pharmacology|March 10, 2017
Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia CellsUn-Ho Jin, Yating Cheng, Beiyan Zhou, et al.BMC Cancer|July 12, 2014
The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasisUn-Ho Jin, Syng-Ook Lee, Catherine Pfent, et al.Biochemical and Biophysical Research Communications|May 15, 2018
Inhibition of pancreatic cancer Panc1 cell migration by omeprazole is dependent on aryl hydrocarbon receptor activation of JNKUn-Ho Jin, Keshav Karki, Sang-Bae Kim, et al.Cancer Prevention Research (Philadelphia, Pa.)|July 5, 2017
Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription FactorsKeshav Karki, Erik Hedrick, Ravi Kasiappan, et al.Oncotarget|March 12, 2016
Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cellsErik Hedrick, Yating Cheng, Un-Ho Jin, et al.Pageof 9